Cargando…
Unique aspects of pain reduction in osteoarthritis of the knee with LMWF-5A
Osteoarthritis of the knee (OAK) is a common form of arthritis that can lead to substantial pain and disability. This commentary highlights key aspects of the recently published phase 3 A Efficacy and Safety Study of Two Doses of Intra-Articular Injection of Ampion™ in Adults With Pain Due to Osteoa...
Autor principal: | McGrath, Brian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5045122/ https://www.ncbi.nlm.nih.gov/pubmed/27790041 http://dx.doi.org/10.2147/OARRR.S71537 |
Ejemplares similares
-
A Randomized Clinical Trial to Evaluate Two Doses of an Intra-Articular Injection of LMWF-5A in Adults with Pain Due to Osteoarthritis of the Knee
por: Bar-Or, David, et al.
Publicado: (2014) -
Intra-articular injection of the anti-inflammatory compound LMWF-5A in adults with severe osteoarthritis: a double-blind prospective randomized controlled multi-center safety and efficacy trial
por: Salottolo, Kristin, et al.
Publicado: (2018) -
LMWF5A suppresses cytokine release by modulating select inflammatory transcription factor activity in stimulated PBMC
por: Thomas, Gregory, et al.
Publicado: (2020) -
The novel immunomodulatory biologic LMWF5A for pharmacological attenuation of the “cytokine storm” in COVID-19 patients: a hypothesis
por: Thomas, Gregory, et al.
Publicado: (2020) -
The anti-inflammatory effect of LMWF5A and N-acetyl kynurenine on macrophages: Involvement of aryl hydrocarbon receptor in mechanism of action
por: Rael, Leonard T., et al.
Publicado: (2018)